Lead exposure aggravates glucose metabolism disorders through gut microbiota dysbiosis and intestinal barrier damage in high‐fat diet‐fed mice
Journal of the Science of Food and Agriculture · 30.03.2024 · 104 (5) · 3057-3068
DOI: 10.1002/jsfa.13197 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Science of Food and Agriculture, online erschienen am 17.12.2023. Verfasst von Nana Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Occupational and Environmental Health, School of Public Health, Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Glucose Metabolism Disorders. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Scientific Funding of China, Postgraduate Research & Practice Innovation Program of Jiangsu Province, Priority Academic Program Development of Jiangsu Higher Education Institutions.
Abstract (Originalsprache)
BACKGROUND Lead (Pb) is an ancient toxic metal and is still a major public health issue. Our previous study found that Pb exposure promotes metabolic disorders in obese mice, but the molecular mechanisms remain unclear. The present study explored the effects of Pb exposure on glucose homeostasis in mice fed a normal diet (ND) and high‐fat diet (HFD) from the perspective of gut microbiota. RESULTS Pb exposure had little effect on glucose metabolism in ND mice, but exacerbated hyperglycemia and insulin resistance, and impaired glucose tolerance in HFD mice. Pb exposure impaired intestinal tight junctions and mucin expression in HFD mice, increasing intestinal permeability and inflammation. Moreover, Pb exposure altered the composition and structure of the gut microbiota and decreased short‐chain fatty acids (SCFAs) levels in HFD mice. Correlation analysis revealed that the gut microbiota and SCFAs were significantly correlated with the gut barrier and glucose homeostasis. Furthermore, the fecal microbiota transplantation from Pb‐exposed HFD mice resulted in glucose homeostasis imbalance, intestinal mucosal structural damage and inflammation in recipient mice. However, Pb did not exacerbate the metabolic toxicity in HFD mice under depleted gut microbiota. CONCLUSION The findings of the present study suggest that Pb induces impairment of glucose metabolism in HFD mice by perturbing the gut microbiota. Our study offers new perspectives on the mechanisms of metabolic toxicity of heavy metals and demonstrates that the gut microbiota may be a target of action for heavy metal exposure. © 2023 Society of Chemical Industry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Occupational and Environmental Health, School of Public Health, Soochow University, Suzhou, China.
ORCID-Profile: Zengli Zhang
Förderung
- National Natural Scientific Funding of China
- Postgraduate Research & Practice Innovation Program of Jiangsu Province
- Priority Academic Program Development of Jiangsu Higher Education Institutions
Zitieren
APA
Wang, N., Gao, X., Huo, Y., Li, Y., Cheng, F., & Zhang, Z. (2024). Lead exposure aggravates glucose metabolism disorders through gut microbiota dysbiosis and intestinal barrier damage in high‐fat diet‐fed mice. Journal of the Science of Food and Agriculture, 104(5), 3057-3068. https://doi.org/10.1002/jsfa.13197
Vancouver
Wang N, Gao X, Huo Y, Li Y, Cheng F, Zhang Z. Lead exposure aggravates glucose metabolism disorders through gut microbiota dysbiosis and intestinal barrier damage in high‐fat diet‐fed mice. Journal of the Science of Food and Agriculture. 2024;104(5):3057-3068. doi:10.1002/jsfa.13197
BibTeX
@article{Wang2024,
author = {Wang, Nana and Gao, Xue and Huo, Yuan and Li, Yuting and Cheng, Fangru and Zhang, Zengli},
title = {Lead exposure aggravates glucose metabolism disorders through gut microbiota dysbiosis and intestinal barrier damage in high‐fat diet‐fed mice},
journal = {Journal of the Science of Food and Agriculture},
year = {2024},
volume = {104},
number = {5},
pages = {3057--3068},
doi = {10.1002/jsfa.13197}
}
EUVIMED